Transitional cell carcinoma of the prostate: Diagnosis, staging and management

Stephen W. Hardeman, Mark S. Soloway

Research output: Contribution to journalArticle

15 Citations (Scopus)

Abstract

Over a 5-year period, 21 patients were diagnosed with transitional cell carcinoma (TCC) of the prostate. Tumor was primary to the prostate in 3 patients, but was associated with TCC of the bladder in the remaining 18. Ten patients developed TCC of the prostate following intravesical therapy for TCC of the bladder. Patients were staged according to local tumor extent, with 2 having disease confined to the prostatic urothelium, 7 showing invasion into ducts and 12 with stromal involvement. None of the 21 patients had metastatic disease at diagnosis. A total of 14 patients underwent radical cystoprostatectomy as primary therapy, while the remaining 7 were managed without radical surgery, receiving intravesical therapy, transurethral resection, systemic chemotherapy, and radiotherapy, singly or in combination. Minimum follow-up was 22 months, with an average of 35 months. Twelve patients (57%) are alive with no evidence of disease, 3 (14%) are alive with tumor and 6 (29%) have died - 5 (24%) of progressive tumor.

Original languageEnglish
Pages (from-to)170-174
Number of pages5
JournalWorld Journal of Urology
Volume6
Issue number3
DOIs
StatePublished - Dec 1 1988
Externally publishedYes

Fingerprint

Transitional Cell Carcinoma
Prostate
Neoplasms
Urinary Bladder
Urothelium
Radiotherapy
Therapeutics
Drug Therapy

ASJC Scopus subject areas

  • Urology

Cite this

Transitional cell carcinoma of the prostate : Diagnosis, staging and management. / Hardeman, Stephen W.; Soloway, Mark S.

In: World Journal of Urology, Vol. 6, No. 3, 01.12.1988, p. 170-174.

Research output: Contribution to journalArticle

Hardeman, Stephen W. ; Soloway, Mark S. / Transitional cell carcinoma of the prostate : Diagnosis, staging and management. In: World Journal of Urology. 1988 ; Vol. 6, No. 3. pp. 170-174.
@article{5a205c093cc844139d6bbe1f78ca717e,
title = "Transitional cell carcinoma of the prostate: Diagnosis, staging and management",
abstract = "Over a 5-year period, 21 patients were diagnosed with transitional cell carcinoma (TCC) of the prostate. Tumor was primary to the prostate in 3 patients, but was associated with TCC of the bladder in the remaining 18. Ten patients developed TCC of the prostate following intravesical therapy for TCC of the bladder. Patients were staged according to local tumor extent, with 2 having disease confined to the prostatic urothelium, 7 showing invasion into ducts and 12 with stromal involvement. None of the 21 patients had metastatic disease at diagnosis. A total of 14 patients underwent radical cystoprostatectomy as primary therapy, while the remaining 7 were managed without radical surgery, receiving intravesical therapy, transurethral resection, systemic chemotherapy, and radiotherapy, singly or in combination. Minimum follow-up was 22 months, with an average of 35 months. Twelve patients (57{\%}) are alive with no evidence of disease, 3 (14{\%}) are alive with tumor and 6 (29{\%}) have died - 5 (24{\%}) of progressive tumor.",
author = "Hardeman, {Stephen W.} and Soloway, {Mark S.}",
year = "1988",
month = "12",
day = "1",
doi = "10.1007/BF00326796",
language = "English",
volume = "6",
pages = "170--174",
journal = "World Journal of Urology",
issn = "0724-4983",
publisher = "Springer Verlag",
number = "3",

}

TY - JOUR

T1 - Transitional cell carcinoma of the prostate

T2 - Diagnosis, staging and management

AU - Hardeman, Stephen W.

AU - Soloway, Mark S.

PY - 1988/12/1

Y1 - 1988/12/1

N2 - Over a 5-year period, 21 patients were diagnosed with transitional cell carcinoma (TCC) of the prostate. Tumor was primary to the prostate in 3 patients, but was associated with TCC of the bladder in the remaining 18. Ten patients developed TCC of the prostate following intravesical therapy for TCC of the bladder. Patients were staged according to local tumor extent, with 2 having disease confined to the prostatic urothelium, 7 showing invasion into ducts and 12 with stromal involvement. None of the 21 patients had metastatic disease at diagnosis. A total of 14 patients underwent radical cystoprostatectomy as primary therapy, while the remaining 7 were managed without radical surgery, receiving intravesical therapy, transurethral resection, systemic chemotherapy, and radiotherapy, singly or in combination. Minimum follow-up was 22 months, with an average of 35 months. Twelve patients (57%) are alive with no evidence of disease, 3 (14%) are alive with tumor and 6 (29%) have died - 5 (24%) of progressive tumor.

AB - Over a 5-year period, 21 patients were diagnosed with transitional cell carcinoma (TCC) of the prostate. Tumor was primary to the prostate in 3 patients, but was associated with TCC of the bladder in the remaining 18. Ten patients developed TCC of the prostate following intravesical therapy for TCC of the bladder. Patients were staged according to local tumor extent, with 2 having disease confined to the prostatic urothelium, 7 showing invasion into ducts and 12 with stromal involvement. None of the 21 patients had metastatic disease at diagnosis. A total of 14 patients underwent radical cystoprostatectomy as primary therapy, while the remaining 7 were managed without radical surgery, receiving intravesical therapy, transurethral resection, systemic chemotherapy, and radiotherapy, singly or in combination. Minimum follow-up was 22 months, with an average of 35 months. Twelve patients (57%) are alive with no evidence of disease, 3 (14%) are alive with tumor and 6 (29%) have died - 5 (24%) of progressive tumor.

UR - http://www.scopus.com/inward/record.url?scp=0024214918&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0024214918&partnerID=8YFLogxK

U2 - 10.1007/BF00326796

DO - 10.1007/BF00326796

M3 - Article

AN - SCOPUS:0024214918

VL - 6

SP - 170

EP - 174

JO - World Journal of Urology

JF - World Journal of Urology

SN - 0724-4983

IS - 3

ER -